La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors Aug 18 Written By Alex tapper Yahoo Finance Alex tapper Just here to help out.
La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors Aug 18 Written By Alex tapper Yahoo Finance Alex tapper Just here to help out.
